Close

Analyst Ratings for Nektar Therapeutics (NKTR)

NKTR Rating Summary

NKTR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NKTR
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $6.46 (+31.8%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 40%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/8/2022 JPMorgan Jessica Fye Downgrade Underweight
(Neutral)
N/A
(N/A)
4.42
(4.90)
10.86% Details
5/31/2022 Jefferies Roger Song New Coverage Hold
(N/A)
4.00
(12.00)
3.54
(4.90)
38.42% Details
Like NKTR Ratings? Also take a look at BMY, TWST, LLY, VICR

NKTR Ratings News